These results were also further verified in an orthotopic xenograft tumor mouse model of pancreatic cancer (Fig. 6), indicating that alizarin exerts its antitumor activity by targeting the canonical NF-κB pathway. This evidence concerns the gene NFKB1 and neoplasm.